Clinical Trials Browser

Phase 2 × Stomach Neoplasms × pertuzumab × Clear all

NCT02205047 2025-07-31

INNOVATION

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01461057 2018-08-09

JOSHUA

Phase 2 Completed

30 enrolled 9 charts

Gastrointestinal

Stomach Neoplasms